Regulation of serotonin synthesis and release in rat striatum
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
YU Faculty Profile
Abstract
Evidence is presented indicating that cAMP stimulates tryptophan hydroxylase (TrpH), the rate-limiting enzyme for serotonin (5-HT) synthesis. Forskolin, an activator of adenylate cyclase, stimulated 5-HT formation in synaptoneurosomes prepared from rat brain striatum. 8-thio-methyl cAMP enhanced soluble TrpH activity, supporting a direct role of cAMP, probably via protein kinase A (PK-A), in regulating TrpH. In addition to a direct activation of TrpH by PK-A, it was considered whether cAMP induced changes in 5-HT release and thereby indirectly influenced TrpH. The synthesis and release of {dollar}\sp3{dollar}H-5-HT newly synthesized from {dollar}\sp3{dollar}H-tryptophan was evaluated. Forskolin increased the absolute amount of {dollar}\sp3{dollar}H-5-HT released; however the fractional efflux of {dollar}\sp3{dollar}H-5-HT was unchanged. Furthermore, forskolin did not influence 5-HT release from synaptosomes prelabeled with {dollar}\sp3{dollar}H-5-HT. Thus, forskolin increases the pool of releasable 5-HT, but does not stimulate 5-HT synthesis by triggering 5-HT release.;Both basal and forskolin-stimulated 5-HT formation were inhibited by calmidazolium, and anti-calmodulin (CaM) agent. Calmidazolium did not inhibit cAMP formation or 5-HT release. It is concluded that basal and forskolin-stimulated 5-HT synthesis requires CaM-dependent processes independent 5-HT release.;5-HT itself inhibited 5-HT formation; zimelidine, which inhibits 5-HT uptake, diminished this effect. The 5-HT agonists 5-methoxy-3(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole succinate (RU-24969), trimethylphenylpiperazine (TFMPP), and 8-hydroxy-2-(di-n-propylamino)tetralin (DPAT) did not inhibit 5-HT synthesis. These results suggest that 5-HT-inhibited 5-HT synthesis is independent of 5-HT{dollar}\sb{lcub}\rm 1a \ or \ 1b{rcub}{dollar} receptors and may involve intraneuronal entry of 5-HT.;The 5-HT agonists RU-24969, TFMPP, and DPAT stimulated efflux of prelabeled {dollar}\sp3{dollar}H-5-HT. Chlorimipramine, a 5-HT uptake inhibitor, reversed these effects, suggesting that the 5-HT uptake carrier interacts with 5-HT agonists to regulate 5-HT release. In the presence of chlorimipramine, RU-24969 diminished K{dollar}\sp+{dollar}-evoked 5-HT release, presumably by an action at the 5-HT{dollar}\sb{lcub}\rm 1b{rcub}{dollar} autoreceptor. These studies, as well as studies of {dollar}\sp3{dollar}H-DPAT and {dollar}\sp3{dollar}H-5-HT uptake, indicate that the agonist-induced efflux of 5-HT involves the binding of agonist to the uptake carrier without carrier-specific neuronal entry of the agonist and subsequent exchange of agonist for intraneuronal 5-HT. Thus, certain 5-HT{dollar}\sb1{dollar} agonists may act on the outside surface of the uptake carrier to regulate 5-HT release and uptake, but not synthesis, similar to the actions of tricyclic and related antidepressants.